table of content
1 Introduction to Research & Analysis Reports
1.1 CAR-T Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Therapy Overall Market Size
2.1 Global CAR-T Therapy Market Size: 2022 VS 2032
2.2 Global CAR-T Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Therapy Players in Global Market
3.2 Top Global CAR-T Therapy Companies Ranked by Revenue
3.3 Global CAR-T Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR-T Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR-T Therapy Market Size Markets, 2022 & 2032
4.1.2 CD19
4.1.3 CD22
4.1.4 Other
4.2 By Type - Global CAR-T Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR-T Therapy Revenue, 2018-2023
4.2.2 By Type - Global CAR-T Therapy Revenue, 2024-2032
4.2.3 By Type - Global CAR-T Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR-T Therapy Market Size, 2022 & 2032
5.1.2 Acute Lymphocytic Leukemia
5.1.3 Diffuse Large B Cell Lymphoma
5.1.4 Follicular Lymphoma
5.1.5 Chronic Lymphocytic Leukemia
5.1.6 Multiple Myeloma
5.1.7 Other
5.2 By Application - Global CAR-T Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR-T Therapy Revenue, 2018-2023
5.2.2 By Application - Global CAR-T Therapy Revenue, 2024-2032
5.2.3 By Application - Global CAR-T Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global CAR-T Therapy Market Size, 2022 & 2032
6.2 By Region - Global CAR-T Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR-T Therapy Revenue, 2018-2023
6.2.2 By Region - Global CAR-T Therapy Revenue, 2024-2032
6.2.3 By Region - Global CAR-T Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America CAR-T Therapy Revenue, 2018-2032
6.3.2 US CAR-T Therapy Market Size, 2018-2032
6.3.3 Canada CAR-T Therapy Market Size, 2018-2032
6.3.4 Mexico CAR-T Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe CAR-T Therapy Revenue, 2018-2032
6.4.2 Germany CAR-T Therapy Market Size, 2018-2032
6.4.3 France CAR-T Therapy Market Size, 2018-2032
6.4.4 U.K. CAR-T Therapy Market Size, 2018-2032
6.4.5 Italy CAR-T Therapy Market Size, 2018-2032
6.4.6 Russia CAR-T Therapy Market Size, 2018-2032
6.4.7 Nordic Countries CAR-T Therapy Market Size, 2018-2032
6.4.8 Benelux CAR-T Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia CAR-T Therapy Revenue, 2018-2032
6.5.2 China CAR-T Therapy Market Size, 2018-2032
6.5.3 Japan CAR-T Therapy Market Size, 2018-2032
6.5.4 South Korea CAR-T Therapy Market Size, 2018-2032
6.5.5 Southeast Asia CAR-T Therapy Market Size, 2018-2032
6.5.6 India CAR-T Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America CAR-T Therapy Revenue, 2018-2032
6.6.2 Brazil CAR-T Therapy Market Size, 2018-2032
6.6.3 Argentina CAR-T Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Therapy Revenue, 2018-2032
6.7.2 Turkey CAR-T Therapy Market Size, 2018-2032
6.7.3 Israel CAR-T Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia CAR-T Therapy Market Size, 2018-2032
6.7.5 UAE CAR-T Therapy Market Size, 2018-2032
7 CAR-T Therapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Therapy Major Product Offerings
7.1.4 Novartis AG CAR-T Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Therapy Major Product Offerings
7.2.4 Kite Pharma CAR-T Therapy Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer CAR-T Therapy Major Product Offerings
7.3.4 Pfizer CAR-T Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics CAR-T Therapy Major Product Offerings
7.4.4 Juno Therapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation CAR-T Therapy Major Product Offerings
7.5.4 Celgene Corporation CAR-T Therapy Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Company Summary
7.6.2 CARsgen Therapeutics Business Overview
7.6.3 CARsgen Therapeutics CAR-T Therapy Major Product Offerings
7.6.4 CARsgen Therapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.6.5 CARsgen Therapeutics Key News & Latest Developments
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Company Summary
7.7.2 Sorrento Therapeutics Business Overview
7.7.3 Sorrento Therapeutics CAR-T Therapy Major Product Offerings
7.7.4 Sorrento Therapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.7.5 Sorrento Therapeutics Key News & Latest Developments
7.8 Legend Biotech
7.8.1 Legend Biotech Company Summary
7.8.2 Legend Biotech Business Overview
7.8.3 Legend Biotech CAR-T Therapy Major Product Offerings
7.8.4 Legend Biotech CAR-T Therapy Revenue in Global Market (2018-2023)
7.8.5 Legend Biotech Key News & Latest Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Company Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics CAR-T Therapy Major Product Offerings
7.9.4 Atara Biotherapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.9.5 Atara Biotherapeutics Key News & Latest Developments
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Company Summary
7.10.2 Aurora Biopharma Business Overview
7.10.3 Aurora Biopharma CAR-T Therapy Major Product Offerings
7.10.4 Aurora Biopharma CAR-T Therapy Revenue in Global Market (2018-2023)
7.10.5 Aurora Biopharma Key News & Latest Developments
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Company Summary
7.11.2 Autolus Therapeutics PLC Business Overview
7.11.3 Autolus Therapeutics PLC CAR-T Therapy Major Product Offerings
7.11.4 Autolus Therapeutics PLC CAR-T Therapy Revenue in Global Market (2018-2023)
7.11.5 Autolus Therapeutics PLC Key News & Latest Developments
7.12 Bluebird
7.12.1 Bluebird Company Summary
7.12.2 Bluebird Business Overview
7.12.3 Bluebird CAR-T Therapy Major Product Offerings
7.12.4 Bluebird CAR-T Therapy Revenue in Global Market (2018-2023)
7.12.5 Bluebird Key News & Latest Developments
7.13 Carina Biotech
7.13.1 Carina Biotech Company Summary
7.13.2 Carina Biotech Business Overview
7.13.3 Carina Biotech CAR-T Therapy Major Product Offerings
7.13.4 Carina Biotech CAR-T Therapy Revenue in Global Market (2018-2023)
7.13.5 Carina Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
